Safety and Immunogenicity Study of Rabies G Protein Vaccine Administered as a Simulated Post-exposure Immunization in Healthy Volunteers
Phase of Trial: Phase I/II
Latest Information Update: 03 Jul 2019
At a glance
- Drugs Rabies G protein vaccine (Primary)
- Indications Rabies
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Cadila Pharmaceuticals
- 17 Jun 2019 Status changed from planning to completed.
- 18 Jul 2014 Planned number of patients changed to 170 as reported by Clinical Trials Registry - India.
- 03 Jan 2012 New trial record